FDA increases risk level of granola bar recall due to ‘adverse health’ effects
The U.S. Food and Drug Administration ( FDA) has elevated the risk of a recall of various granola bars.
MyChesCo on MSN20h
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal Syndrome
PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, the company’s lead investigational asset aimed at mitigating Cannabis ...